Cynthia Ward

Defiance ETFs launches Europe's first memory-focused fund as analysts predict prices could soar 130%, reshaping the entire global technology supply chain.

The biotech firm's revenue plummeted as losses soared. But behind the numbers is a calculated pivot to cancer therapy, fueled by a Nasdaq debut and new cash.

Tired of costly, complex smart home upgrades? Allesin's new damage-free shades promise easy installation and affordability, bringing smart light control to everyone.

Encore celebrates its global 'Great Place To Work' award. We look past the press release to see if these certifications are just PR or a real driver of growth.

Beyond routine appointments, a deep dive into CIRI's new board reveals a deliberate strategy to tackle ESG, AI, and a new era of investor relations.

SRx Health Solutions rebrands as SRX Global after acquiring a crypto AI firm. But with a history of pivots and a 35% stock drop, is this a brilliant rebirth or a desperate gamble?

The gas shipping giant just secured $206 million for new vessels, but the real story isn't the money—it's the sophisticated financial tool they used.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Rhino Linings' tech was meant to save the DC Reflecting Pool. But the real story involves no-bid contracts, political aesthetics, and a stubborn algae bloom.

A startup's new MR glasses challenge Microsoft HoloLens, but the real story is its bold play to fuel the physical AI revolution with specialized data hardware.

A new report reveals which cannabis brands dominate AI search, just as federal rescheduling creates chaos and opportunity. But with AI often refusing to answer, who wins?

As AI pushes data centers to their limits, CyrusOne appoints ex-Navy Admiral and Meta exec Bob Hennegan to lead U.S. operations. A story of mission-critical leadership.

Formic's new HQ isn't just a building; it's a bet on a new model where manufacturers rent robots, not buy them, leveling the playing field for Main Street.

As ad tech firm Swivel staffs up with industry veterans, it's not just building a company—it's signaling the ad industry's shift from AI hype to execution.

High-grade results, including 170.9 g/t gold, are more than just numbers; they signal a strategic push to restart a historic mine and boost a region.

Biotech firm Azitra is leveraging its engineered microbe tech to tackle rare diseases and enter the $71B cosmeceutical market. Is this a brilliant pivot or a risky bet?

Why is an affordable housing nonprofit building a Hyatt? National CORE's $103M project is a masterclass in creative finance for social good.

APC's new plant is more than an expansion; it's a strategic bet on surging demand for polymers in telecom and utility projects across the nation.

RealTime Reservation's acquisition of STAY isn't just a corporate deal. It's a bold move to capture every dollar you spend on vacation, from booking to checkout.

A new partnership aims to disrupt the opaque PBM industry. By pairing a transparent model with modern tech, it could finally lower your prescription costs.